Business
Evolus to Participate in The Jefferies Global Healthcare Conference
Evolus to Participate in The Jefferies Global Healthcare Conference
About this update from Evolus, Inc. Common Stock
[{"type":"text","content":" NEWPORT BEACH, Calif.--(BUSINESS WIRE)--\nEvolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Jefferies Global Healthcare Conference in New York City.\n\n\nThe fireside chat will take place on Thursday, June 4th, 2026, at 12:50 PM ET.\n\n\nThe fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available 90 days after the date of the presentation.\n\n\nAbout Evolus, Inc.\n\n\nEvolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.\n\n\nJeuveau®, Nuceiva®, and Evolysse® are registered trademarks of Evolus, Inc.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20260519075871/en/\n\nEvolus Contacts:\n\n\nInvestors:\nNareg Sagherian\nVice President, Head of Global Investor Relations and Corporate Communications\nTel: 248-202-9267\nEmail: [email protected]\n\n\nMedia:\nEmail: [email protected]\n\n\nSource: Evolus","length":4673,"tagName":"div"}]